Cerebrospinal fluid tyrosine and 3,4-dihydroxyphenylacetic acid levels in migraine patients.
We studied biochemical parameters related with central dopaminergic neurotransmission in migraine patients during crisis. We determined tyrosine and 3,4-dihydroxyphenylacetic acid (DOPAC) levels in cerebrospinal fluid (CSF) of 47 patients, 29 suffering migraine without aura and 18 suffering migraine with aura, comparing them with 27 control subjects. Tyrosine levels did not differ significantly between patients and controls. The CSF concentration of DOPAC was 0.73 +/- 0.55 ng/ml in the control population, 3.84 +/- 2.08 ng/ml in patients with migraine without aura and 3.30 +/- 1.49 ng/ml in patients suffering migraine with aura. The concentration of DOPAC correlated positively with the intensity of headache. These results suggest that patients with migraine have a central dopaminergic hyperfunction, probably related to a coexisting central dysfunction of noradrenergic neurotransmission.
Castillo
J
J
Department of Neurology, Hospital General de Galicia-Clínico Universitario, Santiago de Compostela, Spain.
Martínez
F
F
Suárez
C
C
Naveiro
J
J
Lema
M
M
Noya
M
M
D015102:3,4-Dihydroxyphenylacetic Acid / Q000134:cerebrospinal fluid*; D000293:Adolescent; D000328:Adult; D001921:Brain / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000503:physiopathology*; D009638:Norepinephrine / Q000502:physiology; D009435:Synaptic Transmission / Q000502:physiology; D014443:Tyrosine / Q000134:cerebrospinal fluid*
D015102:3,4-Dihydroxyphenylacetic Acid; D014443:Tyrosine; D004298:Dopamine; D009638:Norepinephrine